BMPR2 and pulmonary arterial hypertension: Heterozygous mutations in the type II receptor for bone morphogenetic protein (BMPR2), which underlie the majority of the inherited and familial forms of PAH (Guignabert et al., 2015), stimulate the TGFβ–TAK1–MAPK pathway (Nasim et al., 2012).